Temporal bone squamous cell carcinoma (SCC) is the most common primary malignancy of the temporal bone and external auditory canal (EAC), accounting for approximately 80% of all temporal bone malignancies. Annual incidence is 1-6 per million, making it an extremely rare tumor. It may develop in the setting of chronic otitis media (COM) and cholesteatoma; chronic inflammation and irritation are thought to play a role in carcinogenesis. Clinically, it presents with chronic otorrhea, bloody ear discharge, otalgia, and conductive hearing loss. In advanced stages, facial nerve palsy, vertigo, and skull base involvement are seen. The Pittsburgh staging system (T1-T4) is the standard classification guiding surgery. Diagnosis is often delayed because findings overlap with chronic otitis media.
Age Range
50-80
Peak Age
65
Gender
Male predominant
Prevalence
Rare
The pathogenesis of temporal bone SCC is multifactorial. The most important risk factors are chronic otitis media (increased risk in patients with 10-20 year history) and cholesteatoma. The sequence of chronic inflammation → epithelial metaplasia → dysplasia → carcinoma in situ → invasive carcinoma is followed. The tumor originates from the EAC epithelium or middle ear mucosa. Due to the anatomical structure of the EAC, the tumor spreads laterally and medially: lateral spread to the auricle and periauricular soft tissue, medial spread to the middle ear, mastoid, and petrous portion of the temporal bone. Fissures and sutures of the temporal bone (petrotympanic fissure, petrosquamous fissure) form natural pathways for tumor spread. Therefore, perineural/perivascular spread may be seen on imaging even without obvious cortical bone destruction. In advanced stages, the tumor may invade the middle cranial fossa through the tegmen tympani, the posterior fossa through the jugular foramen, and major vessels through the carotid canal. The appearance of aggressive bone destruction on CT results from osteolytic effect and acceleration of bone resorption by tumor enzymes (matrix metalloproteinases).
The combination of aggressive bone destruction (moth-eaten/permeative pattern) with heterogeneously enhancing soft tissue mass in the temporal bone is the most characteristic imaging finding for SCC. This combination differentiates from benign causes like chronic otitis media or cholesteatoma — benign pathologies show smooth scalloping bone erosion, while SCC demonstrates an irregular destructive pattern.
Aggressive bone destruction of the temporal bone cortex: areas of destruction involving the EAC bony walls (especially inferior and posterior), tegmen tympani, sigmoid sinus plate, carotid canal wall, and mastoid cortex are observed. The destruction pattern is permeative/moth-eaten — it must be distinguished from the smooth scalloping pattern of cholesteatoma or chronic otitis media. Bone window CT provides sensitive assessment of destruction. Thin cortical bone structures of the temporal bone (tegmen, otic capsule wall) show early involvement.
Report Sentence
Aggressive bone destruction in the right/left temporal bone involving the ___ region with involvement of EAC bony walls/tegmen tympani/sigmoid sinus plate; temporal bone squamous cell carcinoma should be the primary consideration.
A heterogeneously enhancing soft tissue mass in the EAC and/or middle ear is identified. The mass typically originates from the posterior or inferior wall of the EAC and extends to adjacent structures through bone destruction. Necrotic areas show no enhancement while viable tumor tissue demonstrates heterogeneous enhancement. Periauricular soft tissue invasion, parotid gland involvement, and infratemporal fossa extension are evaluated on contrast-enhanced CT.
Report Sentence
A ___ cm heterogeneously enhancing soft tissue mass in the EAC/middle ear is identified, consistent with primary malignancy when considered with temporal bone destruction.
Abnormal enhancement at the tegmen tympani region and the middle cranial fossa dural surface may be observed on post-contrast T1 fat-sat sequences — this indicates dural invasion or intracranial extension (Pittsburgh T3-T4). Temporal lobe parenchymal invasion (T4) is characterized by focal parenchymal signal abnormality and enhancement beyond dural enhancement. Dural tail sign, unlike in meningioma, is associated with tumoral invasion. Cavernous sinus involvement indicates advanced-stage disease.
Report Sentence
Dural enhancement at the tegmen tympani region/middle cranial fossa is identified on post-contrast fat-sat T1 sequences, consistent with intracranial extension (Pittsburgh T3/T4); neurosurgery consultation is recommended.
On diffusion-weighted imaging (DWI), tumor tissue shows marked signal increase, and diffusion restriction is confirmed with low ADC values on ADC map. This finding reflects high cellularity and dense packing of tumor cells. No diffusion restriction is seen in necrotic areas. DWI is also valuable in differentiating residual/recurrent tumor from post-radiotherapy changes.
Report Sentence
Diffusion restriction is identified in the solid component of the mass on DWI (ADC: ___ × 10⁻³ mm²/s), consistent with malignant tumor tissue.
Bone erosion of the carotid canal wall and/or encasement of the internal carotid artery by tumor may be observed. This finding indicates Pittsburgh T4 staging and surgical contraindication. The degree of bone destruction of the carotid canal wall and the tumor encasement angle around the artery (>270° full encasement) determines surgical planning. Balloon occlusion testing may be required.
Report Sentence
Bone destruction of the carotid canal wall/___-degree tumoral encasement of the internal carotid artery is identified, requiring evaluation for Pittsburgh T4 staging and surgical contraindication.
Tumoral invasion of the facial nerve canal is assessed on MRI. On thin-section T2-weighted sequences (CISS/FIESTA), widening of the facial nerve canal, lumen obliteration, and loss of the interface between adjacent tumor tissue and the nerve are observed. Abnormal enhancement along the facial nerve course is seen on post-contrast T1. Mastoid and tympanic segments are the most commonly involved portions. Knowledge of preoperative facial nerve status is critical for surgical planning and patient counseling.
Report Sentence
Tumoral invasion/widening of the ___ segment of the facial nerve canal is identified; preoperative facial nerve status should be evaluated.
Criteria
Tumor originates from EAC epithelium. Most common type. Starts with posterior and inferior wall destruction of EAC. Pittsburgh T1 limited to EAC, T2 extension to middle ear/mastoid.
Distinct Features
Polypoid or ulcerative mass in EAC, periauricular soft tissue invasion seen early. Parotid gland and TMJ involvement indicates lateral spread.
Criteria
Tumor originates from middle ear mucosa. More commonly develops in the setting of chronic otitis media/cholesteatoma. Ossicular chain destruction is an early finding. Early involvement of tegmen tympani and facial nerve canal due to proximity.
Distinct Features
Tympanic membrane may not be intact. May coexist with cholesteatoma — requires biopsy. Facial nerve palsy develops earlier in middle ear origin cases.
Criteria
T3: Dura, TMJ, facial nerve, or infratemporal fossa involvement. T4: Carotid artery encasement, extensive skull base involvement, intracranial extension, distant metastasis. 5-year survival 30-50% for T3, 0-20% for T4.
Distinct Features
MRI best evaluates dural invasion, carotid canal involvement, and intracranial extension. CT shows extent of bone destruction. MRI + CT combination is the gold standard for staging.
Distinguishing Feature
Cholesteatoma shows smooth scalloping bone erosion, SCC shows aggressive destructive pattern. Cholesteatoma DWI bright, SCC diffusion restriction variable. Cholesteatoma no enhancement, SCC heterogeneous enhancement.
Distinguishing Feature
Malignant otitis externa in diabetic/immunosuppressed patient, bone erosion less aggressive than SCC, no destructive mass. Tc-99m/Ga-67 scintigraphy helpful in differential diagnosis.
Distinguishing Feature
Meningioma shows homogeneous enhancement + dural tail sign, bone hyperostosis (not destruction). SCC shows heterogeneous enhancement + aggressive bone destruction. Meningioma DWI usually no restriction.
Distinguishing Feature
Cholesterol granuloma T1 AND T2 hyperintense (pathognomonic), no/minimal enhancement, smooth expansile lesion. SCC T1 hypointense, significant enhancement, aggressive bone destruction.
Urgency
urgentManagement
surgicalBiopsy
NeededFollow-up
3-monthTreatment is planned according to the Pittsburgh staging system. T1 stage lateral temporal bone resection (LTBR), T2 subtotal temporal bone resection (STBR), T3-T4 extended resection + adjuvant radiotherapy. Carotid artery encasement (>270°) is a surgical contraindication. 5-year survival: T1 100%, T2 80%, T3 50%, T4 0-20%. Cervical lymph node metastasis occurs in 10-20% — neck dissection is recommended for T3-T4. Postoperative follow-up with CT + MRI (every 3 months for the first 2 years, then every 6 months). Biopsy is mandatory for pathological confirmation — diagnostic delay in SCC developing on chronic otitis media is the most important factor increasing mortality.
Treatment is planned according to the Pittsburgh staging system. Early stage (T1-T2) surgical resection (lateral temporal bone resection), advanced stage (T3-T4) extended resection + radiotherapy. Carotid artery encasement or dural invasion limits surgery. 5-year survival is 100% for T1, 0-20% for T4.